| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCY-028 | Myricetin | >98%,Standard References |
|
| DCL-043 | Cyanidin Chloride | >98%,Standard References |
|
| DCQ-060 | Pinocembrin | >98%,Standard References |
|
| DCG-036 | Liquiritigenin | >98%,Standard References |
|
| DC52031 | Naringenin Featured | Naringenin is the predominant flavanone in grapefruit; displays strong anti-inflammatory and antioxidant activities. Naringenin has anti-dengue virus (DENV) activity. |
|
| DCS-076 | Eriodictyol | >98%,Standard References |
|
| DCJ-053 | Methylswertianin | >98%,Standard References |
|
| DCE-001 | Taxifolin | >98%,Standard References |
|
| DCE-002 | Dihydromyricetin | >98%,Standard References |
|
| DCJ-036 | yangonin | >98%,Standard References |
|
| DCG-022 | Phloretin | >98%,Standard References |
|
| DCM-044 | methysticin | >98%,Standard References |
|
| DCE-011 | Cianidanol | >98%,Standard References |
|
| DCB-020 | L-Epicatechin | >98%,Standard References |
|
| DCZ-267 | (-)-Gallocatechin | >98%,Standard References |
|
| DCB-021 | (-)-Epigallocatechin | >98%,Standard References |
|
| DCX-037 | linderalactone Featured | Linderalactone showed significant inhibitory effects on superoxide anion generation by human neutrophils in response to fMLP/CB, values of IC5 is 8.48 μg/mL. |
|
| DCS-008 | Osthole | >98%,Standard References |
|
| DCC-053 | Meranzin | >98%,Standard References |
|
| DCE-020 | dihydromethysticin | >98%,Standard References |
|
| DCY-174 | SkiMMin | >98%,Standard References |
|
| DCQ-014 | Esculin | >98%,Standard References |
|
| DCQ-016 | Dehydrocostuslactone | >98%,Standard References |
|
| DCB-045 | Ulopterol | >98%,Standard References |
|
| DCT-023 | Alantolactone | >98%,Standard References |
|
| DCM-022 | costunolide | >98%,Standard References |
|
| DCY-059 | Isoalantolactone | >98%,Standard References |
|
| DCQ-085 | Arteannuin | >98%,Standard References |
|
| DCZ-114 | Abscisic acid | >98%,Standard References |
|
| DCM-035 | Rosin | >98%,Standard References |
|
